Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc

Decompensated liver cirrhosis has a dismal prognosis, with patients surviving on average for 2–4 years after the first diagnosis of ascites. Albumin is an important tool in the therapy of cirrhotic ascites. By virtue of its oncotic properties, it reduces the risk of cardiovascular dysfunction after...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kurt Grüngreiff, Thomas Gottstein, Dirk Reinhold, Claudia A. Blindauer
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/a20f9cfe3ead4174bc1a66af0e573311
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a20f9cfe3ead4174bc1a66af0e573311
record_format dspace
spelling oai:doaj.org-article:a20f9cfe3ead4174bc1a66af0e5733112021-11-25T18:36:03ZAlbumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc10.3390/nu131140112072-6643https://doaj.org/article/a20f9cfe3ead4174bc1a66af0e5733112021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/4011https://doaj.org/toc/2072-6643Decompensated liver cirrhosis has a dismal prognosis, with patients surviving on average for 2–4 years after the first diagnosis of ascites. Albumin is an important tool in the therapy of cirrhotic ascites. By virtue of its oncotic properties, it reduces the risk of cardiovascular dysfunction after paracentesis. Treatment with albumin also counteracts the development of hepatorenal syndrome and spontaneous bacterial peritonitis. More recently, the positive impact of long-term albumin supplementation in liver disease, based on its pleiotropic non-oncotic activities, has been recognized. These include transport of endo- and exogenous substances, anti-inflammatory, antioxidant and immunomodulatory activities, and stabilizing effects on the endothelium. Besides the growing recognition that effective albumin therapy requires adjustment of the plasma level to normal physiological values, the search for substances with adjuvant activities is becoming increasingly important. More than 75% of patients with decompensated liver cirrhosis do not only present with hypoalbuminemia but also with zinc deficiency. There is a close relationship between albumin and the essential trace element zinc. First and foremost, albumin is the main carrier of zinc in plasma, and is hence critical for systemic distribution of zinc. In this review, we discuss important functions of albumin in the context of metabolic, immunological, oxidative, transport, and distribution processes, alongside crucial functions and effects of zinc and their mutual dependencies. In particular, we focus on the major role of chronic inflammatory processes in pathogenesis and progression of liver cirrhosis and how albumin therapy and zinc supplementation may affect these processes.Kurt GrüngreiffThomas GottsteinDirk ReinholdClaudia A. BlindauerMDPI AGarticleliver cirrhosisalbuminzincNutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 4011, p 4011 (2021)
institution DOAJ
collection DOAJ
language EN
topic liver cirrhosis
albumin
zinc
Nutrition. Foods and food supply
TX341-641
spellingShingle liver cirrhosis
albumin
zinc
Nutrition. Foods and food supply
TX341-641
Kurt Grüngreiff
Thomas Gottstein
Dirk Reinhold
Claudia A. Blindauer
Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
description Decompensated liver cirrhosis has a dismal prognosis, with patients surviving on average for 2–4 years after the first diagnosis of ascites. Albumin is an important tool in the therapy of cirrhotic ascites. By virtue of its oncotic properties, it reduces the risk of cardiovascular dysfunction after paracentesis. Treatment with albumin also counteracts the development of hepatorenal syndrome and spontaneous bacterial peritonitis. More recently, the positive impact of long-term albumin supplementation in liver disease, based on its pleiotropic non-oncotic activities, has been recognized. These include transport of endo- and exogenous substances, anti-inflammatory, antioxidant and immunomodulatory activities, and stabilizing effects on the endothelium. Besides the growing recognition that effective albumin therapy requires adjustment of the plasma level to normal physiological values, the search for substances with adjuvant activities is becoming increasingly important. More than 75% of patients with decompensated liver cirrhosis do not only present with hypoalbuminemia but also with zinc deficiency. There is a close relationship between albumin and the essential trace element zinc. First and foremost, albumin is the main carrier of zinc in plasma, and is hence critical for systemic distribution of zinc. In this review, we discuss important functions of albumin in the context of metabolic, immunological, oxidative, transport, and distribution processes, alongside crucial functions and effects of zinc and their mutual dependencies. In particular, we focus on the major role of chronic inflammatory processes in pathogenesis and progression of liver cirrhosis and how albumin therapy and zinc supplementation may affect these processes.
format article
author Kurt Grüngreiff
Thomas Gottstein
Dirk Reinhold
Claudia A. Blindauer
author_facet Kurt Grüngreiff
Thomas Gottstein
Dirk Reinhold
Claudia A. Blindauer
author_sort Kurt Grüngreiff
title Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
title_short Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
title_full Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
title_fullStr Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
title_full_unstemmed Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
title_sort albumin substitution in decompensated liver cirrhosis: don’t forget zinc
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/a20f9cfe3ead4174bc1a66af0e573311
work_keys_str_mv AT kurtgrungreiff albuminsubstitutionindecompensatedlivercirrhosisdontforgetzinc
AT thomasgottstein albuminsubstitutionindecompensatedlivercirrhosisdontforgetzinc
AT dirkreinhold albuminsubstitutionindecompensatedlivercirrhosisdontforgetzinc
AT claudiaablindauer albuminsubstitutionindecompensatedlivercirrhosisdontforgetzinc
_version_ 1718410969058639872